Jeannie Hoffman-Censits, Xiangying Chu, Vitaly Margulis, Daniel Shevrin, Suzanne Cole, Ruben Raychaudhuri, Kriti Mittal, Sarah P. Psutka, Abhishek Tripathi, Noah M. Hahn, Michael A. Carducci, Petros Grivas. "ECOG ACRIN EA8192 cohort C: A phase II trial of neoadjuvant gemcitabine/durvalumab in patients (pts) with high grade (HG) upper tract urothelial carcinoma (UTUC) ineligible for cisplatin-based chemotherapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.749